Chemical Structure : KNX-115
货号: PC-49323Not For Human Use, Lab Use Only.
KNX-115 (KNX115) is a potent, selective inhibitor of plasmodium falciparum myosin A (PfMyoA), inhibits PfMyoA actin-activated ATPase with Ki of 17 nM, inhibits full-length PfMyoA with IC50 of <40 nM in in vitro actin-activated myosin ATPase assay.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KNX-115 (KNX115) is a potent, selective inhibitor of plasmodium falciparum myosin A (PfMyoA), inhibits PfMyoA actin-activated ATPase with Ki of 17 nM, inhibits full-length PfMyoA with IC50 of <40 nM in in vitro actin-activated myosin ATPase assay.
KNX-115 shows >50-fold selectivity against cardiac, skeletal, and smooth muscle myosins.
KNX-115 inhibits the blood and liver stages of Plasmodium with an EC50 of 110 nM, with negligible liver cell toxicity.
KNX-115 inhibits sporozoite cell traversal and blocks the gametocyte to oocyst conversion in the mosquito.
KNX-115 displays a similar killing profile to pyrimethamine and parasites are totally killed after 96 hours of treatment.
KNX-115 is equally effective at inhibiting a panel of Plasmodium strains resistant to experimental and marketed antimalarials.
| 分子量 | 349.42 | |
| 分子式 | C15H15N3O3S2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Trivedi DV, et al. Proc Natl Acad Sci U S A. 2026 Jul 28;123(30):e2608709123.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright